Neumora to Announce Updates at J.P. Morgan Healthcare Conference
Neumora plans to unveil significant updates at the J.P. Morgan Healthcare Conference in January. Stay tuned for insights into their latest advancements.
Topic
Neumora
A collection of 7 issues
Neumora's $342M Cash Secures Mid-2026 Runway
Neumora maintains a strong cash balance of $342 million, ensuring financial stability and operational runway into mid-2026 despite recent setbacks. Discover more about Neumora's financial strategy.
Neumora's Stock Plummets After Depression Drug Trial Fails
Neumora Therapeutics Inc.'s shares drop after their depression drug's final-stage trial failure. Discover what this means for investors and the company's future.
Neumora's Share Decline Impacts Healthcare Sentiment
Neumora's significant share drop may lead to negative sentiment in the healthcare sector. Discover potential impacts on market dynamics.
Neumora's Robust $340M Cash Reserve Ensures Stability Until 2026
Discover how Neumora's impressive $340 million cash balance provides financial stability, ensuring operational security until mid-2026. Learn more now.
Neumora's Depression Drug Trial Fails, Shares Plunge 82%
Neumora Therapeutics' depression drug falls short in final-stage trial, leading to an 82% pre-market share drop. Discover the impact on Neumora's future prospects.
Neumora to Share Key Updates at JPMorgan Healthcare Conference
Neumora to present significant updates at the JPMorgan Healthcare Conference starting January 13. Stay informed on the latest in healthcare advancements.